Contact:Margaret Keller
Phone:(434)243-5457
E-mail:mfk8e@virginia.edu
The purpose of the study is to evaluate whether creatine is more effective than placebo in slowing clinical worsening in patients with Parkinson's Disease. The study involves taking creatine or placebo twice a day, blood draws, assessment of Parkinson's symptoms, completion of surveys, and testing of thinking skills. Participants are seen initially every 3 months, extending to every 6 months, some of which are phone visits. The trial last for at least 5 years. Clinic visits are at the Fontaine Adult Neurology Clinic. Participants must be within 5 years of their diagnosis and have been treated with levodopa or a dopamine agonist for less than 2 years.
Study-related exams, tests and experimental medication provided free of charge.
No compensation is provided for this study.
Contact Information:
For more information please contact:
" Insert Margaret Keller RN MS
" Phone 434-243-5457; email mfk8e@virginia.edu
" Insert IRB-HSR # 12781
Principal Investigator: G. Frederick Wooten, Jr. MD
|
|
Primary Investigator: Wooten George, F